Swivel Convertible Child Safety Seat to Improve Usage
Launched by MINNESOTA HEALTHSOLUTIONS · Mar 4, 2025
Trial Information
Current as of July 01, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new type of child car seat designed to make it easier and safer for parents and caregivers to install and use. The traditional car seats can be tricky to set up correctly, which sometimes leads to mistakes that could put children at risk in car accidents. The new swivel car seat aims to reduce these common installation errors, particularly focusing on a feature called the “top tether,” which helps secure the seat more firmly. The researchers want to see if this new design leads to fewer mistakes compared to regular car seats.
To participate in this trial, you need to be between 18 and 65 years old and care for a child who is up to 4 years old. It’s important that you’ve installed a child safety seat in the past two years and can lift and install the seat into your vehicle. Participants will have the chance to try out the swivel car seat, share their thoughts on how easy it was to use, and help researchers understand if this new design can improve child safety in cars. The trial is not yet recruiting, so keep an eye out for updates if you're interested!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Between the ages of 18 and 65
- • Care provider to a child who is up to 4 years of age
- • Have installed a child safety seat in the last 2 years
- • Able to lift and install a child safety seat into a vehicle
- • English speaking.
- Exclusion Criteria:
- • Not meeting any of the above
About Minnesota Healthsolutions
Minnesota HealthSolutions is a leading clinical trial sponsor dedicated to advancing healthcare through innovative research and development. With a strong commitment to improving patient outcomes, the organization conducts rigorous clinical trials across various therapeutic areas, focusing on both safety and efficacy. Leveraging a collaborative approach, Minnesota HealthSolutions partners with healthcare professionals, regulatory bodies, and patients to facilitate the timely delivery of groundbreaking therapies. Their expertise in clinical operations and adherence to ethical standards ensures that each study is conducted with the highest level of integrity and scientific rigor.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Columbus, Ohio, United States
Patients applied
Trial Officials
Julie Mansfield, PhD
Principal Investigator
Ohio State University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported